GlassScriptPhysician profile
Sohail Hanif
NPI 1770559031
$4,709.66
in general payments reported to CMS, 2019-2025
25 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $769 · 2020: $526 · 2021: $737 · 2022: $843 · 2023: $716 · 2024: $973 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,834.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $970.95 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $618.31 | 2019-2024 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $541.43 | 2019-2023 | Brilinta, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $433.37 | 2019-2024 | Jardiance |
| Medtronic, INC. | $375.64 | 2021-2025 | Turbohawk, Abre, Hawkone |
| Janssen Pharmaceuticals, INC | $370.66 | 2019-2024 | Xarelto, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $296.60 | 2019-2023 | Lifevest |
| Pfizer INC. | $236.96 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $144.12 | 2021-2024 | Verquvo |
| Boston Scientific Corporation | $101.69 | 2021-2024 | Avvigo Guidance System |
| Amgen INC. | $91.58 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $91.18 | 2022-2024 | Optimizer |
| Esperion Therapeutics, INC. | $69.03 | 2020-2024 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $56.78 | 2021 | |
| Amarin Pharma, INC. | $46.39 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $42.21 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.98 | 2019 | |
| Shockwave Medical, INC | $34.84 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $30.48 | 2025 | Biopharma Sol - Contract Manuf |
| Medtronic Vascular, INC. | $25.00 | 2019 | |
| Novo Nordisk INC | $24.74 | 2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $18.99 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.52 | 2020 | |
| Philips North America LLC | $14.90 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohail Hanif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.